Literature DB >> 15130345

[Study on the mechanism of intrauterine infection of hepatitis B virus].

Ya-fei Yue1, Hui Jiang, Lei Shi, Li-fang Li, Bao-shui Xi, You-lian Yu, Guang-feng Chen.   

Abstract

OBJECTIVE: To study the possible mechanism of intrauterine infection of hepatitis B virus (HBV).
METHODS: HBV DNA was examined in amniotic fluid, and vaginal secretion of 59 HBsAg positive mothers and in cord blood of their neonates by PCR. Ten negative hepatitis B virus marker (HBVM) mothers and their neonates were served as control. HBsAg and HBcAg in placenta were examined by avidin biotin complex (ABC) method.
RESULTS: The detection rate of HBV DNA in amniotic fluid, vaginal secretion and neonatal cord blood of the study group were 47.5% (28/59), 52.5% (31/59) and 45.8% (27/59) respectively. HBsAg and HBcAg in placenta was distributed in the following descending order: maternal decidual cells, trophoblastic cells, villous mesenchymal cells and villous capillary endothelial cells. But the distribution was in reverse order in 4 placentas. HBsAg and HBcAg were detected in amniotic epithelial cells in 32 mothers.
CONCLUSION: The main route of HBV transmission from mother to fetus is transplacental, from maternal side of placenta to fetal side. However, HBV intrauterine infection may take place through other routes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130345

Source DB:  PubMed          Journal:  Zhonghua Fu Chan Ke Za Zhi        ISSN: 0529-567X


  6 in total

1.  Expression of HBsAg and HBcAg in the ovaries and ova of patients with chronic hepatitis B.

Authors:  Feng Ye; Ya-Fei Yue; Shu-Hong Li; Tian-Yan Chen; Shu-Ling Zhang; Gui-Qin Bai; Min Liu
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

2.  A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG.

Authors:  Qin Xu; Lin Xiao; Xiao-Bo Lu; Yue-Xin Zhang; Xia Cai
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus.

Authors:  M Yu; Q Jiang; Y Ji; H Jiang; K Wu; L Ju; X Tang; M Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

4.  A disappearing vertical infection: will hepatitis B be a forgotten disease in children?

Authors:  Byung-Ho Choe
Journal:  Korean J Intern Med       Date:  2014-04-29       Impact factor: 2.884

5.  A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population.

Authors:  Li-Zhang Chen; Wen-Qi Zhou; Shu-Shan Zhao; Zhi-Yu Liu; Shi-Wu Wen
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

6.  Quantitative HBsAg and Qualitative HBeAg Predicts Intrauterine Placental Infection and Umbilical Blood Cord in Pregnant Women.

Authors:  Erry Gumilar Dachlan; Cahyanti Nugraheni; Alphania Rahniayu; Muhammad Ilham Aldika Akbar
Journal:  J Family Reprod Health       Date:  2020-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.